Boehringer Ingelheim Press Releases

Wealth of worldwide evidence on Pradaxa® including first clinical data on long-term efficacy and safety of a novel oral anticoagulant to be presented at AHA Scientific Sessions

Boehringer Ingelheim presents robust pipeline highlighting its Respiratory R&D

The Respimat® success story: Boehringer Ingelheim doubles its production capacity

European approval granted for Trajenta® (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes

NICE recommends treatment with alteplase is started as early as possible, within 4.5 hours of onset of ischaemic stroke symptoms

Boehringer Ingelheim congratulates Nobel Prize winner Prof. Brian Kobilka

Final Phase IIb interferon-free hepatitis C data from Boehringer Ingelheim to be presented at AASLD

Analyses presented at EASD support Trajenta® (linagliptin) as effective and well-tolerated for patients with type 2 diabetes with different background therapies

Lilly and Boehringer Ingelheim Present Health Outcomes Data for Investigational Novel Basal Insulin Analogue

Clinical data for investigational SGLT2 inhibitor, empagliflozin*, demonstrates potential for oral treatment in type 2 diabetes

Boehringer Ingelheim’s novel project transfer program enables fast track to launch for biopharmaceuticals

Unprecedented progression-free survival benefit with afatinib* associated with clinically meaningful improvements in life-limiting lung cancer symptoms and better quality of life

Join the mission on World Heart Day 2012: call for signatures

Change in the Board of Managing Directors at Boehringer Ingelheim

Boehringer Ingelheim opens European Veterinary Research Center in Hanover

New data from Boehringer Ingelheim and Lilly showcase strength of Diabetes Alliance at EASD Annual Meeting

Recruitment complete for two pivotal Phase III studies of nintedanib* in patients with idiopathic pulmonary fibrosis

CHMP recommends indication for the use of Trajenta® (linagliptin) tablets as add-on therapy to insulin in adults with Type 2 Diabetes in Europe